Articles | AmbioPharm

peptide drug approvals

An Approval for Apellis

June 8, 2021

Bivalirudin (“Angiomax”): Rescue Therapy in Covid Cases

May 5, 2021

AmbioPharm 100 Years of Insulin

100 Years of Insulin: A Triumph of Science

May 4, 2021

AmbioPharm Green Chemistry

Green Peptide Chemistry and Sustainability Publication

April 20, 2021

Streamlining the Path to Peptide Market Supply

March 17, 2021

New Peptide Toxin-Derived KV1.3 Channel Inhibitor Publication in the British Journal of Pharmacology

March 2, 2021

New Cyclic Peptides Review

February 9, 2021

AmbioPharm Peptide 2021 COVID19 Vaccine Image

Goodbye 2020: A Peptide Drug Recap and New Webcasts

January 4, 2021

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS